Qiagen NV

QGEN:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/22/21 EST
54.33UNCH (UNCH)
Volume
9,090
Close
54.33quote price arrow up+0.60 (+1.12%)
Volume
522,021
52 week range
32.97 - 55.27

...

Loading . . .

KEY STATS

  • Open54.06
  • Day High54.69
  • Day Low53.86
  • Prev Close53.73
  • 52 Week High55.27
  • 52 Week High Date10/12/20
  • 52 Week Low32.97
  • 52 Week Low Date02/04/20
  • Market Cap12,540.99M
  • Shares Out230.83M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.31
  • 1 Year % Change56.03

RATIOS/PROFITABILITY

  • EPS (TTM)0.82
  • P/E (TTM)65.93
  • Fwd P/E (NTM)22.31
  • EBITDA (MRQ)684.74M
  • ROE (MRQ)7.39%
  • Revenue (MRQ)1,712.58M
  • Gross Margin (MRQ)66.50%
  • Net Margin (MRQ)11.18%
  • Debt To Equity (MRQ)65.95%

EVENTS

  • Earnings Date02/01/2021
  • Ex Div Date01/25/2017
  • Div Amount1.08
  • Split Date-
  • Split Factor-

Latest Qiagen NV News

There is no recent news for this security.

Latest QGEN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay...
Thierry Bernard
Chief Executive Officer
Roland Sackers
Chief Financial Officer
Address
Hulsterweg 82
Venlo
5912 PL
Netherlands